Illumina Innovation Fund II GP, L.L.C. bought ALMR
April 20, 2026 · Form 4 insider transaction
Illumina Innovation Fund II GP, L.L.C. bought 235,294 shares of Alamar Biosciences, Inc. at $17.00 per share, a transaction worth $4.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Footnotes
The securities are held by Illumina Innovation Fund III, L.P. ("IIF III"). Illumina Innovation Fund III GP, L.L.C. ("IIF III GP") is the general partner of IIF III. Mr. Naclerio, a member of the Issuer's board of directors, is the sole managing member of IIF III GP and may be deemed to have voting, investment and dispositive power with respect to the securities held by IIF III. Each of IIF III GP and Mr. Naclerio disclaim beneficial ownership over the securities held by IIF III, except to the extent of their respective pecuniary interests therein, if any.